Cargando…
Serum Anti-Mullerian Hormone Levels Might Indicate Premenopausal Endometrial Lesions
Background: Endometrial proliferative lesions (EPL) usually refer to endometrial hyperplasia (EH) and endometrial cancer (EC). Among patients with premenopausal EPL who wish to preserve their fertility, only those with EH and early-stage EC have the possibility to undergo fertility preservation ther...
Autores principales: | Yao, Yingsha, Shi, Liujing, Zhu, Xiaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650321/ https://www.ncbi.nlm.nih.gov/pubmed/37958197 http://dx.doi.org/10.3390/diagnostics13213301 |
Ejemplares similares
-
Four differentially expressed exosomal miRNAs as prognostic biomarkers and therapy targets in endometrial cancer: Bioinformatic analysis
por: Yao, Yingsha, et al.
Publicado: (2023) -
Does the Serum Vitamin D Status and its Possible Effect on Serum Anti-Müllerian Hormone Levels Predict Fertility in Premenopausal Women?
por: Lawal, Oyinkansola Islamiyat
Publicado: (2021) -
Association between cadmium and anti-Mullerian hormone in premenopausal women at particular ages
por: Lee, Yu min, et al.
Publicado: (2018) -
Anti-Müllerian Hormone Expression in Endometrial Cancer Tissue
por: Gowkielewicz, Marek, et al.
Publicado: (2019) -
Serum Müllerian inhibiting substance levels are lower in premenopausal women with breast precancer and cancer
por: McCoy, Andrew C, et al.
Publicado: (2011)